Bill Text: TX HR44 | 2025-2026 | 89th Legislature | Introduced
Bill Title: Recognizing February 26, 2025, as Hypertrophic Cardiomyopathy Awareness Day.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-11-25 - Filed [HR44 Detail]
Download: Texas-2025-HR44-Introduced.html
| 89R5211 TBO-F | ||
| By: Lalani | H.R. No. 44 | |
|
|
||
| WHEREAS, Hypertrophic Cardiomyopathy Awareness Day is taking | ||
| place on February 26, 2025, and this occasion provides a fitting | ||
| opportunity to promote better understanding of this health issue; | ||
| and | ||
| WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic | ||
| cardiovascular disease that involves thickening of the heart muscle | ||
| and can potentially lead to debilitating symptoms and serious | ||
| complications, including heart failure, atrial fibrillation, | ||
| stroke, and in rare cases, sudden cardiac death; and | ||
| WHEREAS, HCM is the most common inheritable heart disease; it | ||
| can affect anyone, regardless of age, gender, or ethnicity, and it | ||
| has a reported prevalence ranging from 1 in 200 individuals to 1 in | ||
| 500 individuals in the general population; recent reports show that | ||
| the number of people in Texas who have HCM range from 58,000 to | ||
| nearly 147,000, although approximately 85 percent of cases remain | ||
| undiagnosed; and | ||
| WHEREAS, HCM shares symptoms with other common | ||
| cardiovascular and pulmonary diseases, such as shortness of breath, | ||
| chest pain, fatigue, palpitations, and fainting, and those | ||
| similarities make it difficult to accurately diagnose HCM; in | ||
| addition, the all-cause mortality risk is three to four times | ||
| higher in patients with HCM than that of the general population; it | ||
| is important that patients know their medical history and stay | ||
| informed about the signs and symptoms of HCM; and | ||
| WHEREAS, In order to help identify a risk of both genetic and | ||
| congenital cardiac disorders, health care providers conduct | ||
| thorough screenings with cardiac health questions; they may also | ||
| conduct several tests, including an echocardiogram, a cardiac MRI, | ||
| or genetic testing to confirm a family history of HCM, and they must | ||
| examine the heart to diagnose HCM; and | ||
| WHEREAS, Following a diagnosis of HCM, patients are advised | ||
| to work with their health care providers to learn more about the | ||
| disease and different management options, such as prescription | ||
| medicines and surgical treatments; and | ||
| WHEREAS, Hypertrophic cardiomyopathy is a serious and | ||
| life-threatening disease, and the observance of Hypertrophic | ||
| Cardiomyopathy Awareness Day unites people around the world in | ||
| their commitment to improving the quality of life for patients; | ||
| now, therefore, be it | ||
| RESOLVED, That the House of Representatives of the 89th Texas | ||
| Legislature hereby recognize February 26, 2025, as Hypertrophic | ||
| Cardiomyopathy Awareness Day and urge all Texans to learn more | ||
| about the disease; and, be it further | ||
| RESOLVED, That an official copy of this resolution be | ||
| prepared for the Hypertrophic Cardiomyopathy Association as an | ||
| expression of high regard by the Texas House of Representatives. | ||
